Argonaute2 Suppresses Drosophila Fragile X Expression Preventing Neurogenesis and Oogenesis Defects

Anita S.-R. Pepper, Rebecca W. Beerman, Balpreet Bhogal et al. · 2009

Read Argonaute2 Suppresses Drosophila Fragile X Expression Preventing Neurogenesis and Oogenesis Defects by Anita S.-R. Pepper, Rebecca W. Beerman, Balpreet Bhogal et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007618.txt.

Description

Anita Pepper and colleagues published a study in PLOS ONE in 2009 on the gene behind fragile X syndrome. That condition, a leading inherited cause of intellectual disability, comes from silencing the FMR1 gene. Yet too much of the gene's product is also harmful; dosage must be kept in range. How normal expression levels are maintained was unclear. The team studied a protein called Argonaute2 in fruit flies and its effect on the fly version of the gene.

Argonaute2 suppresses fragile X expression in the fly. That suppression prevents defects in nerve development and egg formation. So a small-RNA pathway protein acts as a dosage guard for this sensitive gene. Dosage guards matter where both shortage and excess cause disease. The fly work gives human fragile X research a new regulatory thread to pull. It also shows Argonaute proteins doing more than silencing targets outright.

Catalog record

CREATORAnita S.-R. Pepper, Rebecca W. Beerman, Balpreet Bhogal et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007618

Browse the full library · About the Tower of Babel